Free Trial

Getinge AB (publ) (OTCMKTS:GNGBY) Sees Significant Growth in Short Interest

Getinge AB (publ) logo with Medical background

Getinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 45,200 shares, an increase of 1,406.7% from the December 15th total of 3,000 shares. Based on an average trading volume of 158,500 shares, the days-to-cover ratio is currently 0.3 days.

Getinge AB (publ) Stock Down 1.1 %

GNGBY stock traded down $0.19 during trading on Monday, reaching $16.60. The stock had a trading volume of 50,233 shares, compared to its average volume of 105,433. The company has a market capitalization of $4.52 billion, a price-to-earnings ratio of 28.14 and a beta of 0.77. Getinge AB has a one year low of $14.84 and a one year high of $22.85. The company's 50 day moving average is $16.15 and its two-hundred day moving average is $18.39.

Getinge AB (publ) (OTCMKTS:GNGBY - Get Free Report) last posted its quarterly earnings results on Friday, October 18th. The company reported $0.21 earnings per share for the quarter. Getinge AB (publ) had a net margin of 5.04% and a return on equity of 8.27%. The company had revenue of $755.49 million during the quarter.

About Getinge AB (publ)

(Get Free Report)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.

Featured Articles

Should You Invest $1,000 in Getinge AB (publ) Right Now?

Before you consider Getinge AB (publ), you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Getinge AB (publ) wasn't on the list.

While Getinge AB (publ) currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

3 Stocks Insiders Are Selling, But Analysts Still Love
NVIDIA Unveils Game-Changing Tech, But Stock Dips
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines